|
Changes on non refridgerated Ribo
|
|
0
|
50
|
10 September 2026
|
|
Reaction to Ribociclib
|
|
5
|
154
|
4 September 2026
|
|
Help us shape our submission to NICE
|
|
0
|
91
|
4 September 2026
|
|
Anyone on Enhertu?
|
|
6
|
6445
|
24 August 2026
|
|
Sign the Petition & Help Extend Lives: Enhertu Now
|
|
9
|
225
|
21 August 2026
|
|
Everolimus+Exemestane
|
|
2
|
444
|
18 August 2026
|
|
Succesful on Capecitabine
|
|
34
|
8646
|
6 August 2026
|
|
Mirtazapine anyone?
|
|
5
|
131
|
30 July 2026
|
|
Weekly Paclitaxel Secondaries
|
|
5
|
173
|
25 July 2026
|
|
Pause in Capivasertib due to rash side effect
|
|
2
|
79
|
17 July 2026
|
|
Tamoxifen for metastatic breast cancer
|
|
9
|
1297
|
14 July 2026
|
|
Capivasertib and faslodex?
|
|
5
|
163
|
16 June 2026
|
|
Support needed
|
|
3
|
368
|
10 June 2026
|
|
Capecitabine when to take
|
|
3
|
288
|
7 June 2026
|
|
Lobular Breast Cancer
|
|
17
|
5210
|
6 June 2026
|
|
BROC - has anyone tried this supplement?
|
|
8
|
1886
|
31 May 2026
|
|
Calivasertib side effects
|
|
4
|
144
|
13 May 2026
|
|
We’re looking for people to help shape our response to the Scottish Medicines Consortium’s (SMC) appraisal of elacestrant (korserdu) for treating ER positive, HER-2 negative secondary breast cancer with an ESR1 mutation
|
|
1
|
181
|
11 May 2026
|
|
Sore lump in groin
|
|
1
|
137
|
28 April 2026
|
|
Surgery for Secondary
|
|
5
|
542
|
23 April 2026
|
|
Side effects after chemo
|
|
0
|
127
|
15 April 2026
|
|
Letrozole not working
|
|
3
|
1775
|
9 April 2026
|
|
Change in meds
|
|
6
|
380
|
5 April 2026
|
|
Palbociclib blood results
|
|
8
|
1293
|
5 April 2026
|
|
Atrophy
|
|
12
|
2017
|
4 April 2026
|
|
Have you received capivasertib with fulvestrant (Truqap with Faslodex)?
|
|
2
|
748
|
1 April 2026
|
|
Brain met, surgery, SRS now Docetaxel & Phesgo
|
|
14
|
1229
|
31 March 2026
|
|
Am I the only one with metastatic triple negative HER2neg in the bones?
|
|
4
|
806
|
27 March 2026
|
|
Talazoparib treatment
|
|
0
|
79
|
25 March 2026
|
|
Nephrostomy advice
|
|
10
|
431
|
18 March 2026
|